ConductScience.org, home

Paper40134771

A supervised machine-learning analysis of doxorubicin-loaded electrospun nanofibers and their anticancer activity capabilities.

Rostami M and 7 others. Front Bioeng Biotechnol, 2025. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A supervised machine-learning analysis of doxorubicin-loaded electrospun nanofibers and their anticancer activity capabilities. Papers, record 40134771. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40134771

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A supervised machine-learning analysis of doxorubicin-loaded electrospun nanofibers and their anticancer activity capabilities.
PubMed
Journal
Front Bioeng Biotechnol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-03-27
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rostami MMohammadreza
2Gharibshahian MMaliheh
3Mostafavi MMehrnaz
4Sufali AAli
5Golmohammadi MMahsa
6Barati MRMohammad Reza
7Maleki RReza
8Beheshtizadeh NNima

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137322139Electrospun nanofiber membrane diameter prediction using a combined response surface methodology and machine learning approach.Sci Rep2023https://conductscience.org/library/papers/37322139PubMed
236948284Doxorubicin-loaded micelles in tumor cell-specific chemotherapy.Environ Res2023https://conductscience.org/library/papers/36948284PubMed
326306537Antitumor Activity of Doxorubicin-Loaded Carbon Nanotubes Incorporated Poly(Lactic-Co-Glycolic Acid) Electrospun Composite Nanofibers.Nanoscale Res Lett2015https://conductscience.org/library/papers/26306537PubMed
432260617Inhibition of orthotopic secondary hepatic carcinoma in mice by doxorubicin-loaded electrospun polylactide nanofibers.J Mater Chem B2013https://conductscience.org/library/papers/32260617PubMed
525579518An overview of doxorubicin formulations in cancer therapy.J Cancer Res Ther2014https://conductscience.org/library/papers/25579518PubMed
634078252Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics.J Biomater Sci Polym Ed2021https://conductscience.org/library/papers/34078252PubMed
739014260Doxorubicin as a Drug Repurposing for Disruption of α-Chymotrypsinogen-A Aggregates.Protein J2024https://conductscience.org/library/papers/39014260PubMed
834636282Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy.Expert Rev Anticancer Ther2021https://conductscience.org/library/papers/34636282PubMed
932805104Harnessing a Novel Machine-Learning-Assisted Evolutionary Algorithm to Co-optimize Three Characteristics of an Electrospun Oil Sorbent.ACS Appl Mater Interfaces2020https://conductscience.org/library/papers/32805104PubMed
1039495464Small Molecules Targeting Mitochondria: A Mechanistic Approach to Combating Doxorubicin-Induced Cardiotoxicity.Cardiovasc Toxicol2025https://conductscience.org/library/papers/39495464PubMed
1137977290
Incorporation of doxorubicin and CoFe2O4 nanoparticles into the cellulose acetate phthalate / polyvinyl alcohol (core)/ polyurethane (shell) nanofibers against A549 human lung cancer during chemotherapy/hyperthermia combined method.
Int J Pharm2024https://conductscience.org/library/papers/37977290PubMed
1235283223Artificial intelligence to bring nanomedicine to life.Adv Drug Deliv Rev2022https://conductscience.org/library/papers/35283223PubMed
1336103274Membrane-Wrapped Nanoparticles for Enhanced Chemotherapy of Acute Myeloid Leukemia.ACS Biomater Sci Eng2022https://conductscience.org/library/papers/36103274PubMed
1434585584Dynamic Pore Modulation of Stretchable Electrospun Nanofiber Filter for Adaptive Machine Learned Respiratory Protection.ACS Nano2021https://conductscience.org/library/papers/34585584PubMed
1535360005Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.Int J Nanomedicine2022https://conductscience.org/library/papers/35360005PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42020465Predictive modeling of controlled drug release from polysaccharide-based systems using gradient boosting and metaheuristic optimization.Sci Rep2026https://conductscience.org/library/papers/42020465

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40134771

GET https://conductscience.org/api/papers/v1/40134771/authors